Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 39,89 € (+30,79%). La mediana è 38,84 € (+27,34%).
| Acquista |
15 |
| Mantieni |
2 |
| Vendi |
0 |
Notizie Vai al feed delle notizie
Medline shares plunge in premarket trading after disappointing Q2 results
Medline shares lost 11.4% in premarket trading after the release of disappointing second-quarter 2026 results, intensifying concerns over profitability and cost pressure. The weak Q1 figures—showing declining net income and a compressed margin—set the backdrop, with further pressure from a UBS price-target cut and the resignation of the COO. The stock fell to $37.25, well below the analyst consensus of about $50.92 and closer to its 52-week low than its high. » Altro su de.investing.com
Medline to become primary supplier for Allina Health
Medline has signed a primary supplier agreement with Allina Health that gives Allina access to medical‑surgical products and distribution services for its 12 hospitals and more than 90 clinics in Minnesota and western Wisconsin. The agreement is intended to strengthen supply security and to drive standardization of products, processes and data across the health system. Medline thereby expands an existing partnership and will provide supply‑chain solutions for Allina Health’s network. » Altro su de.investing.com
Medline rents 1.6 million square feet of warehouse space in Northern California after fire
Medline has leased two distribution centers in Northern California totaling more than 1.6 million square feet: a 925,000‑square‑foot facility in Tracy for immediate use and a 709,000‑square‑foot site in Stockton scheduled to begin operations in January 2027. Capacity in the region rises about 45% within a month and replaces a previously fire‑destroyed 1‑million‑square‑foot center in Tracy. The new Tracy facility is less than 10 miles from the former site and is expected to take its first shipments in the coming months; in California Medline plans to expand distribution space to nearly 5 million square feet by mid‑2027. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 6,73 Mld | 15,26% |
| Utile lordo | 1,94 Mld | 32,30% |
| Utile netto | 52,57 Mln | 81,39% |
| EBITDA | 577,42 Mln | 19,17% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 25,29 Mld € |
Numero di azioni | 845,61 Mln |
Massimo/minimo a 52 settimane | 43,91 € - 28,04 € |
| Dividendi | No |
Beta | -0,41 |
Rapporto P/E | 40,29 |
Rapporto PEG | -1,34 |
Rapporto P/B | 2,57 |
Rapporto P/S | 0,98 |
Profilo aziendale
| Nome | MEDLINE INC. CL. A O.N. |
| CEO | James Boyle |
| Dipendenti | 45.000 |
Deep Dive
Scopri gli asset
Gli azionisti di MEDLINE INC. CL. A O.N. investono anche nei seguenti asset



